Bank of America’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.6M | Buy |
787,949
+146,266
| +23% | +$1.01M | ﹤0.01% | 2935 |
|
|
2026
Q1 | $2.71M | Buy |
641,683
+540,748
| +536% | +$2.42M | ﹤0.01% | 3904 |
|
|
2025
Q4 | $381K | Buy |
100,935
+58,785
| +139% | +$114K | ﹤0.01% | 5053 |
|
|
2025
Q3 | $67.9K | Buy |
42,150
+7,571
| +22% | +$13.5K | ﹤0.01% | 6747 |
|
|
2025
Q2 | $75.7K | Buy |
34,579
+33,957
| +5,459% | +$52.1K | ﹤0.01% | 6649 |
|
|
2025
Q1 | $672 | Buy |
622
+50
| +9% | +$59 | ﹤0.01% | 7480 |
|
|
2024
Q4 | $595 | Buy |
572
+46
| +9% | +$53 | ﹤0.01% | 7379 |
|
|
2024
Q3 | $658 | Sell |
526
-51
| -9% | -$62 | ﹤0.01% | 7326 |
|
|
2024
Q2 | $687 | Buy |
+577
| New | +$785 | ﹤0.01% | 7293 |
|
|
2024
Q1 | – | Sell |
-42
| Closed | -$44 | – | 8138 |
|
|
2023
Q4 | $44 | Buy |
+42
| New | +$45 | ﹤0.01% | 7517 |
|
|
2023
Q1 | – | Sell |
-48
| Closed | -$114 | – | 8230 |
|
|
2022
Q4 | $114 | Buy |
+48
| New | +$135 | ﹤0.01% | 7647 |
|
|
2022
Q3 | – | Sell |
-24,268
| Closed | -$54K | – | 8163 |
|
|
2022
Q2 | $54K | Buy |
24,268
+2,612
| +12% | +$7.66K | ﹤0.01% | 6800 |
|
|
2022
Q1 | $145K | Sell |
21,656
-10,144
| -32% | -$59.3K | ﹤0.01% | 6654 |
|
|
2021
Q4 | $176K | Sell |
31,800
-12,091
| -28% | -$91.5K | ﹤0.01% | 6568 |
|
|
2021
Q3 | $403K | Buy |
+43,891
| New | +$407K | ﹤0.01% | 5803 |
|
|
2021
Q2 | – | Sell |
-400
| Closed | -$3K | – | 8054 |
|
|
2021
Q1 | $3K | Hold |
400
| – | – | ﹤0.01% | 7195 |
|
|
2020
Q4 | $2K | Buy |
+400
| New | +$1.6K | ﹤0.01% | 6952 |
|
|
2020
Q2 | – | Sell |
-1,185
| Closed | -$2K | – | 7104 |
|
|
2020
Q1 | $2K | Buy |
+1,185
| New | +$3.05K | ﹤0.01% | 6647 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | – | – | 7354 |
|
|
2018
Q3 | $0 | Buy |
+4
| New | +$276 | ﹤0.01% | 7451 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7228 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7246 |
|
|
2017
Q2 | – | Sell |
-5
| Closed | -$4.35K | – | 7151 |
|
|
2017
Q1 | $5K | Buy |
5
+4
| +400% | +$6.62K | ﹤0.01% | 6677 |
|
|
2016
Q4 | $3K | Buy |
+1
| New | +$5.82K | ﹤0.01% | 6791 |
|
Other funds holding SLS
AFM
Bank of America's SLS Position: Q2 2026 in Review
Bank of America increased its SELLAS Life Sciences (SLS) stake by 23% in Q2 2026, buying an estimated $1.01M and bringing the position to 787,949 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2935.
Bank of America first reported a position in SLS in Q4 2016 and has held it in 21 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.
- Bank of America held 787,949 shares of SELLAS Life Sciences worth $11.6M as of Q2 2026.
- Bank of America bought 146,266 SELLAS Life Sciences shares in Q2 2026, an estimated $1.01M.
- SELLAS Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2935 holding.
- Bank of America first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 21 quarters since.
- 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.